Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study "AFASAK I"

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

ECG verified atrial fibrillation.

Exclusion Criteria

Anticoagulation therapy for more than six months, cerebrovascular event within previous 30 days, contraindication for aspirin or warfarin, previous side effects of either medication, pregnancy, blood pressure consistently above 180/100 mm, heart surgery with valve replacement, rheumatic heart disease, alcoholism, sinus rhythm.